TY - JOUR
KW - buprenorphine
KW - Buprenorphine/therapeutic use
KW - Drug Prescriptions/statistics & numerical data
KW - Health Policy
KW - Health Services Accessibility/legislation & jurisprudence
KW - Humans
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/statistics & numerical data
KW - opioid-related disorders
KW - Physicians/legislation & jurisprudence/statistics & numerical data
KW - Private Practice
KW - Public Policy/legislation & jurisprudence
KW - Rural Health Services/statistics & numerical data
KW - Substance abuse treatment
KW - Substance Abuse Treatment Centers/statistics & numerical data
KW - Substance-Related Disorders/prevention & control
KW - United States
KW - Urban Health Services/statistics & numerical data
AU - B. D. Stein
AU - R. L. Pacula
AU - A. J. Gordon
AU - R. M. Burns
AU - D. L. Leslie
AU - M. J. Sorbero
AU - S. Bauhoff
AU - T. W. Mandell
AU - A. W. Dick
A1 - 
BT - The Milbank quarterly
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
CP - 3
CY - United States
DO - 10.1111/1468-0009.12137
IS - 3
JF - The Milbank quarterly
PB - Milbank Memorial Fund
PP - United States
PY - 2015
SN - 1468-0009; 0887-378X
SP - 561
EP - 583
EP - 
T1 - Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties
T2 - The Milbank quarterly
TI - Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 26350930
U3 - 10.1111/1468-0009.12137
VL - 93
VO - 1468-0009; 0887-378X
Y1 - 2015
ER -